CEBPZ and acute myeloid leukemia: The prognosis of CBF-AML has traditionally been classified as favorable, particularly when treated with cytarabine-based intensive chemotherapy regimens, presented as high complete remission (CR) rates and relatively improved survival outcomes compared to other AML subtypes [7,8].